Literature DB >> 20424638

Oxygen therapy reduces secondary hemorrhage after thrombolysis in thromboembolic cerebral ischemia.

Li Sun1, Wei Zhou, Christian Mueller, Clemens Sommer, Sabine Heiland, Alexander T Bauer, Hugo H Marti, Roland Veltkamp.   

Abstract

Hyperbaric oxygen (HBO) and normobaric hyperoxia (NBO) protect the brain parenchyma and the cerebral microcirculation against ischemia. We studied their effect on secondary hemorrhage after thrombolysis in two thromboembolic middle cerebral artery occlusion (MCAO) (tMCAO) models. Beginning 60 minutes after tMCAO with either thrombin-induced thromboemboli (TT) or calcium-induced thromboemboli (CT), spontaneously hypertensive rats (n=96) breathed either air, 100% O(2) (NBO), or 100% O(2) at 3 bar (HBO) for 1 hour. Immediately thereafter, recombinant tissue plasminogen activator (rt-PA, 9 mg/kg) was injected. Although significant reperfusion was observed after thrombolysis in TT-tMCAO, vascular occlusion persisted in CT-tMCAO. In TT-tMCAO, NBO and HBO significantly reduced diffusion-weighted imaging-magnetic resonance imaging (MRI) lesion volume and postischemic blood-brain barrier (BBB) permeability on postcontrast T1-weighted images. NBO and, significantly more potently, HBO reduced macroscopic hemorrhage on T2* MRI and on corresponding postmortem cryosections. Oxygen therapy lowered hemoglobin content and attenuated activation of matrix metalloproteinases in the ischemic hemisphere. In contrast, NBO and HBO failed to reduce infarct size in CT but both decreased BBB damage and microscopic hemorrhagic transformation. Only HBO reduced hemoglobin extravasation in the ischemic hemisphere. In conclusion, NBO and HBO decrease infarct size after thromboembolic ischemia only if recanalization is successful. As NBO and HBO also reduce postthrombolytic intracerebral hemorrhage, combining the two with thrombolysis seems promising.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20424638      PMCID: PMC2949252          DOI: 10.1038/jcbfm.2010.50

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  34 in total

Review 1.  Hyperbaric oxygen and cerebral physiology.

Authors:  John W Calvert; Julian Cahill; John H Zhang
Journal:  Neurol Res       Date:  2007-03       Impact factor: 2.448

2.  Hyperbaric oxygen decreases infarct size and behavioral deficit after transient focal cerebral ischemia in rats.

Authors:  R Veltkamp; D S Warner; F Domoki; A D Brinkhous; J F Toole; D W Busija
Journal:  Brain Res       Date:  2000-01-17       Impact factor: 3.252

3.  Normobaric hyperoxia reduces MRI diffusion abnormalities and infarct size in experimental stroke.

Authors:  Aneesh B Singhal; Rick M Dijkhuizen; Bruce R Rosen; Eng H Lo
Journal:  Neurology       Date:  2002-03-26       Impact factor: 9.910

4.  A pilot study of normobaric oxygen therapy in acute ischemic stroke.

Authors:  Aneesh B Singhal; Thomas Benner; Luca Roccatagliata; Walter J Koroshetz; Pamela W Schaefer; Eng H Lo; Ferdinando S Buonanno; R Gilberto Gonzalez; A Gregory Sorensen
Journal:  Stroke       Date:  2005-03-10       Impact factor: 7.914

5.  Prediction of hemorrhagic transformation after thrombolytic therapy of clot embolism: an MRI investigation in rat brain.

Authors:  C Neumann-Haefelin; G Brinker; U Uhlenküken; F Pillekamp; K-A Hossmann; M Hoehn
Journal:  Stroke       Date:  2002-05       Impact factor: 7.914

6.  Perfusion-weighted MRI using gadobutrol as a contrast agent in a rat stroke model.

Authors:  S Heiland; T Benner; W Reith; M Forsting; K Sartor
Journal:  J Magn Reson Imaging       Date:  1997 Nov-Dec       Impact factor: 4.813

7.  Hyperbaric oxygen-induced attenuation of hemorrhagic transformation after experimental focal transient cerebral ischemia.

Authors:  Zhiyong Qin; Murat Karabiyikoglu; Ya Hua; Robert Silbergleit; Yangdong He; Richard F Keep; Guohua Xi
Journal:  Stroke       Date:  2007-02-22       Impact factor: 7.914

Review 8.  Hyperbaric oxygen in the treatment of acute ischemic stroke: an unsettled issue.

Authors:  N Nighoghossian; P Trouillas
Journal:  J Neurol Sci       Date:  1997-09-01       Impact factor: 3.181

9.  Normobaric hyperoxia and delayed tPA treatment in a rat embolic stroke model.

Authors:  Nils Henninger; Bernt T Bratane; Birgul Bastan; James Bouley; Marc Fisher
Journal:  J Cereb Blood Flow Metab       Date:  2008-09-03       Impact factor: 6.200

10.  Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials.

Authors:  Werner Hacke; Geoffrey Donnan; Cesare Fieschi; Markku Kaste; Rüdiger von Kummer; Joseph P Broderick; Thomas Brott; Michael Frankel; James C Grotta; E Clarke Haley; Thomas Kwiatkowski; Steven R Levine; Chris Lewandowski; Mei Lu; Patrick Lyden; John R Marler; Suresh Patel; Barbara C Tilley; Gregory Albers; Erich Bluhmki; Manfred Wilhelm; Scott Hamilton
Journal:  Lancet       Date:  2004-03-06       Impact factor: 79.321

View more
  32 in total

1.  Endothelial dysfunction abrogates the efficacy of normobaric hyperoxia in stroke.

Authors:  Hwa Kyoung Shin; Fumiaki Oka; Ji Hyun Kim; Dmitriy Atochin; Paul L Huang; Cenk Ayata
Journal:  J Neurosci       Date:  2014-11-12       Impact factor: 6.167

2.  Vascular Dysfunction in Brain Hemorrhage: Translational Pathways to Developing New Treatments from Old Targets.

Authors:  Paul A Lapchak; Qiang Wu
Journal:  J Neurol Neurophysiol       Date:  2011

3.  Only very early oxygen therapy attenuates posthemorrhagic edema formation and blood-brain barrier disruption in murine intracerebral hemorrhage.

Authors:  Wei Zhou; Marilena Marinescu; Roland Veltkamp
Journal:  Neurocrit Care       Date:  2015-02       Impact factor: 3.210

4.  Delayed hyperbaric oxygen therapy induces cell proliferation through stabilization of cAMP responsive element binding protein in the rat model of MCAo-induced ischemic brain injury.

Authors:  Jun Mu; Robert P Ostrowski; Yoshiteru Soejima; William B Rolland; Paul R Krafft; Jiping Tang; John H Zhang
Journal:  Neurobiol Dis       Date:  2012-11-10       Impact factor: 5.996

5.  Matrix metalloproteinase-2-mediated occludin degradation and caveolin-1-mediated claudin-5 redistribution contribute to blood-brain barrier damage in early ischemic stroke stage.

Authors:  Jie Liu; Xinchun Jin; Ke J Liu; Wenlan Liu
Journal:  J Neurosci       Date:  2012-02-29       Impact factor: 6.167

6.  Hyperbaric Oxygen Reduces Infarction Volume and Hemorrhagic Transformation Through ATP/NAD+/Sirt1 Pathway in Hyperglycemic Middle Cerebral Artery Occlusion Rats.

Authors:  Qin Hu; Anatol Manaenko; Hetao Bian; Zongduo Guo; Jun-Long Huang; Zhen-Ni Guo; Peng Yang; Jiping Tang; John H Zhang
Journal:  Stroke       Date:  2017-05-11       Impact factor: 7.914

Review 7.  Hyperbaric oxygen therapy in acute ischemic stroke: a review.

Authors:  Zheng Ding; Wesley C Tong; Xiao-Xin Lu; Hui-Ping Peng
Journal:  Interv Neurol       Date:  2014-08

8.  Ischemic neurons activate astrocytes to disrupt endothelial barrier via increasing VEGF expression.

Authors:  Ying-Na Li; Rong Pan; Xu-Jun Qin; Wei-Lin Yang; Zhifeng Qi; Wenlan Liu; Ke Jian Liu
Journal:  J Neurochem       Date:  2013-12-06       Impact factor: 5.372

Review 9.  Endothelial Targets in Stroke: Translating Animal Models to Human.

Authors:  Anuska V Andjelkovic; Jianming Xiang; Svetlana M Stamatovic; Ya Hua; Guohua Xi; Michael M Wang; Richard F Keep
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-09-12       Impact factor: 8.311

Review 10.  Matrix metalloproteinases as therapeutic targets for stroke.

Authors:  Yi Yang; Gary A Rosenberg
Journal:  Brain Res       Date:  2015-04-25       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.